Strategy in the Surgical Treatment of Primary Spinal Tumors

Author:

Williams Richard1,Foote Matthew2,Deverall Hamish3

Affiliation:

1. Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Queensland, Australia

2. Department of Radiation Oncology, Princess Alexandra Hospital, University of Queensland, Brisbane, Queensland, Australia

3. Department of Orthopaedics, Princess Alexandra Hospital, University of Queensland, Brisbane, Queensland, Australia

Abstract

Primary spine tumors are rare, accounting for only 4% of all tumors of the spine. A minority of the more common primary benign lesions will require surgical treatment, and most amenable malignant lesions will proceed to attempted resection. The rarity of malignant primary lesions has resulted in a paucity of historical data regarding optimal surgical and adjuvant treatment and, although we now derive benefit from standardized guidelines of overall care, management of each neoplasm often proceeds on a case-by-case basis, taking into account the individual characteristics of patient operability, tumor resectability, and biological potential. This article aims to provide an overview of diagnostic techniques, staging algorithms and the authors’ experience of surgical treatment alternatives that have been employed in the care of selected benign and malignant lesions. Although broadly a review of contemporary management, it is hoped that the case illustrations given will serve as additional “arrows in the quiver” of the treating surgeon.

Publisher

SAGE Publications

Subject

Neurology (clinical),Orthopedics and Sports Medicine,Surgery

Reference45 articles.

1. Primary bone tumours of the spine: a 42-year survey from the Leeds Regional Bone Tumour Registry

2. Boriani S Weinstein J N Differential diagnosis and surgical treatment of primary benign and malignant neoplasms In: Frymoyer J W, ed. The Adult Spine Philadelphia, PA Lippincott-Raven 1997 951–987

3. Karnofsky D A Burchenal J H The clinical evaluation of chemotherapeutic agents in cancer In: MacLeod C M, ed. Evaluation of Chemotherapeutic Agents New York, NY Columbia University Press 1949 196

4. Cancer prevalence in the United Kingdom: estimates for 2008

5. Prognostic factors and outcome of pelvic, sacral, and spinal chondrosarcomas

Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3